Ercan YENİLMEZ, Rıza Aytaç ÇETİNKAYA, Burak SARIKAYA, Sinem AKKAYA IŞIK, Orhan BAYLAN, Levent GÖRENEK

ARCHİTECT ANTİ HCV TESTİNİN DÜŞÜK RİSKLİ POPÜLASYONDAKİ TANISAL GÜVENİLİRLİĞİ Diagnostic Reliability of Architect Anti Hcv Tests in a Low-Risk Population

ÖZET

Anahtar Kelimeler:

ARCHİTECT ANTİ HCV TESTİNİN DÜŞÜK RİSKLİ POPÜLASYONDAKİ TANISAL GÜVENİLİRLİĞİ Diagnostic Reliability of Architect Anti Hcv Tests in a Low-Risk Population

PDF

___

1. Omata M, Kanda T, Wei L, Yu M-L, Chuang W-L, Ibrahim A, et al. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatology international. 2016;10(5):681-701. 2. Pawlotsky JM, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G et al. EASL recommendations on treatment of hepatitis C 2018. J Hepatol. 2018 Aug;69(2):461-511. 3. Kamili S, Drobeniuc J, Araujo AC, Hayden TM. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis. 2012 Jul;55 Suppl 1:S43-8. 4. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clinical Microbiology and Infection. 2015;21(11):1020-6. 5. Grad R, Thombs BD, Tonelli M et al. Recommendations on hepatitis C screening for adults. CMAJ. 2017 Apr 24; 189(16): E594–604. 6. European Association for Study of Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2014 Feb;60(2):392-420. 7. Architect system Anti HCV, Abbott Laboratories; [cited 2019 Feb 18]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050042c.pdf 8. Kuhnert WL. Department of Health and Human Services; [cited 2019 Feb 18]. Available from: https://www.cdc.gov/hepatitis/hcv/pdfs/architectletter_5-24-07.pdf 9. Centers for Diseases and Prevention. Signal-to-Cut–Off Ratios for Commercially Available Assays; [cited 2019 Feb 18]. Available from: https://www.cdc.gov/hepatitis/hcv/labtesting.htm 10. Altuğlu İ, Gürsel D, Aksoy A, Orman M, Erensoy S. Anti-HCV sinyal/eşik değer oranının Hepatit C virüs enfeksiyonu tanısında rolü ve önemi. Ege Tıp Dergisi 2011;50(4): 223-8.